This Article Full Text Full Text (PDF) All Versions of this Article: jhc.2008.951954v1 57/1/29    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Jørgensen, L. H. Articles by Schrøder, H. D. Search for Related Content PubMed PubMed Citation Articles by Jørgensen, L. H. Articles by Schrøder, H. D. Social Bookmarking                      What's this?

Secreted Protein Acidic and Rich in Cysteine (SPARC) in Human Skeletal Muscle

Louise H. Jørgensen, Stine J. Petersson, Jeeva Sellathurai, Ditte C. Andersen, Susanne Thayssen, Dorte J. Sant, Charlotte H. Jensen and Henrik D. Schrøder

Institute of Clinical Research (LHJ,SJP,JS,HDS) and Immunology and Microbiology, Institute of Medical Biology (DCA,CHJ), University of Southern Denmark, Odense, Denmark, and Department of Clinical Pathology, Odense University Hospital, Odense, Denmark (LHJ,SJP,JS,DCA,ST,DJS,HDS)

Correspondence to: Henrik Daa Schrøder, Department of Clinical Pathology, Odense University Hospital, J.B. Winsloewsvej 15,2, DK-5000 Odense C, Denmark. E-mail: henrik.daa.schroeder{at}ouh.regionsyddanmark.dk

Secreted protein acidic and rich in cysteine (SPARC)/osteonectin is expressed in different tissues during remodeling and repair, suggesting a function in regeneration. Several gene expression studies indicated that SPARC was expressed in response to muscle damage. Studies on myoblasts further indicated a function of SPARC in skeletal muscle. We therefore found it of interest to study SPARC expression in human skeletal muscle during development and in biopsies from Duchenne and Becker muscular dystrophy and congenital muscular dystrophy, congenital myopathy, inclusion body myositis, and polymyositis patients to analyze SPARC expression in a selected range of inherited and idiopathic muscle wasting diseases. SPARC-positive cells were observed both in fetal and neonatal muscle, and in addition, fetal myofibers were observed to express SPARC at the age of 15–16 weeks. SPARC protein was detected in the majority of analyzed muscle biopsies (23 of 24), mainly in mononuclear cells of which few were pax7 positive. Myotubes and regenerating myofibers also expressed SPARC. The expression-degree seemed to reflect the severity of the lesion. In accordance with these in vivo findings, primary human-derived satellite cells were found to express SPARC both during proliferation and differentiation in vitro. In conclusion, this study shows SPARC expression both during muscle development and in regenerating muscle. The expression is detected both in satellite cells/myoblasts and in myotubes and muscle fibers, indicating a role for SPARC in the skeletal muscle compartment. (J Histochem Cytochem 57:29–39, 2009)

Key Words: skeletal muscle • secreted protein acidic and rich in cysteine/osteonectin/BM-40 • congenital myopathy • muscular dystrophy • myogenesis • satellite cell

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				J. Shin, S. G. Velleman, J. D. Latshaw, M. P. Wick, Y. Suh, and K. Lee The ontogeny of delta-like protein 1 messenger ribonucleic acid expression during muscle development and regeneration: Comparison of broiler and Leghorn chickens Poult. Sci., July 1, 2009; 88(7): 1427 - 1437. [Abstract] [Full Text] [PDF]

Guidelines | Subscriptions | About | exPRESS - Current - Archive | Business Information | Contact

The Journal of Histochemistry & Cytochemistry is owned, published, and licensed by The Histochemical Society © 2009